0001213900-23-041960.txt : 20230522
0001213900-23-041960.hdr.sgml : 20230522
20230522160127
ACCESSION NUMBER: 0001213900-23-041960
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230518
FILED AS OF DATE: 20230522
DATE AS OF CHANGE: 20230522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oron Assaf
CENTRAL INDEX KEY: 0001792310
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 23944339
MAIL ADDRESS:
STREET 1: C/O BIOMX LTD.
STREET 2: 7 PINHAS SAPIR ST., FLOOR 2
CITY: NESS ZIONA
STATE: L3
ZIP: 7414002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BiomX Inc.
CENTRAL INDEX KEY: 0001739174
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 EINSTEIN ST., 4TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
BUSINESS PHONE: (972) 72 394 2377
MAIL ADDRESS:
STREET 1: 22 EINSTEIN ST., 4TH FLOOR
CITY: NESS ZIONA
STATE: L3
ZIP: 7414003
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20180430
4
1
ownership.xml
X0407
4
2023-05-18
0
0001739174
BiomX Inc.
PHGE
0001792310
Oron Assaf
C/O BIOMX INC.
22 EINSTEIN ST., FLOOR 4
NESS ZIONA
L3
7414003
ISRAEL
0
1
0
0
Chief Business Officer
0
Common Stock
2023-05-18
4
P
0
1201
0.2727
A
1201
D
Common Stock
2023-05-19
4
P
0
6521
0.2809
A
7722
D
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.2701 to $0.2750, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.2752 to $0.2898, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.
/s/ Assaf Oron
2023-05-22